Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

2.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, Khan NA, Herman RJ, Bacon SL, Cloutier L, Dawes M, Rabkin SW, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Feldman RD, Lindsay P, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Sharma M, Reid DJ, Tobe SW, Poirier L, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2013 May;29(5):528-42. doi: 10.1016/j.cjca.2013.01.005. Epub 2013 Mar 29.

PMID:
23541660
3.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, Honos G, Herman RJ, Schiffrin EL, Bolli P, Wilson T, Feldman RD, Lindsay MP, Hemmelgarn BR, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Lamarre-Cliché M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk G, Burgess E, Lewanczuk R, Dresser GK, Penner B, Hegele RA, McFarlane PA, Sharma M, Campbell NR, Reid D, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2012 May;28(3):270-87. doi: 10.1016/j.cjca.2012.02.018. Review.

PMID:
22595447
4.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, Burgess E, Lamarre-Cliché M, McLean D, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad GV, Lebel M, Campbell TS, Lindsay MP, Herman RJ, Larochelle P, Feldman RD, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Lewanczuk R, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2011 Jul-Aug;27(4):415-433.e1-2. doi: 10.1016/j.cjca.2011.03.015. English, French.

PMID:
21801975
5.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2010 May;26(5):249-58. Review.

6.

A truncated erythropoietin receptor EPOR-T is associated with hypertension susceptibility.

Carruthers SG.

Clin Pharmacol Ther. 2009 Aug;86(2):134-6. doi: 10.1038/clpt.2009.119.

PMID:
19621008
7.

Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.

Saadi H, Nagelkerke N, Carruthers SG, Benedict S, Abdulkhalek S, Reed R, Lukic M, Nicholls MG.

Diabetes Res Clin Pract. 2008 Jun;80(3):392-8. doi: 10.1016/j.diabres.2008.01.008. Epub 2008 Feb 20.

PMID:
18282631
8.

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction.

Carruthers SG.

Evid Based Med. 2007 Dec;12(6):185. No abstract available.

PMID:
18063745
9.

Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates.

Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholls MG, Kazam E, Algawi K, Al-Kaabi J, Leduc C, Sabri S, El-Sadig M, Elkhumaidi S, Agarwal M, Benedict S.

Diabetes Res Clin Pract. 2007 Dec;78(3):369-77. Epub 2007 May 25.

PMID:
17532085
10.

Nicorandil reduced coronary events in stable angina.

Carruthers SG.

ACP J Club. 2002 Nov-Dec;137(3):83. No abstract available.

PMID:
12418823
11.
12.

Elderly patients with hypertension should retain 'special' status.

Carruthers SG.

Can J Cardiol. 2002 Jun;18(6):645-7. Review. No abstract available.

PMID:
12107421
13.
14.

Recall to a general practitioner or to a nurse clinic improved assessment in patients with coronary artery disease.

Carruthers SG.

ACP J Club. 2002 Jan-Feb;136(1):35. No abstract available.

PMID:
11829576
15.

Grapefruit juice--felodipine interaction in the elderly.

Dresser GK, Bailey DG, Carruthers SG.

Clin Pharmacol Ther. 2000 Jul;68(1):28-34.

PMID:
10945313
16.

1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, Floras JS, Haynes RB, Honos G, Leenen FH, Leiter LA, Logan AG, Myers MG, Spence JD, Zarnke KB.

CMAJ. 1999;161 Suppl 12:S1-17.

17.
20.

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S.

Lancet. 1998 Jun 13;351(9118):1755-62.

PMID:
9635947
21.

Familial studies of heritability of alpha1-adrenergic receptor responsiveness in superficial veins.

Gupta A, Carruthers SG.

Clin Pharmacol Ther. 1997 Sep;62(3):322-6.

PMID:
9333108
22.

Variability in prescription drug utilization: issues for research.

Anis AH, Carruthers SG, Carter AO, Kierulf J.

CMAJ. 1996 Mar 1;154(5):635-40.

23.
24.

Adverse effects of alpha 1-adrenergic blocking drugs.

Carruthers SG.

Drug Saf. 1994 Jul;11(1):12-20. Review.

PMID:
7917078
25.

Early effects of cardiovascular drugs--do they predict clinical outcomes?

Carruthers SG.

Int J Clin Pharmacol Ther. 1994 Mar;32(3):107-12. Review.

PMID:
8205369
27.

Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration.

Pollak PT, Sharma AD, Carruthers SG.

Br J Clin Pharmacol. 1993 Aug;36(2):125-7.

28.

Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction.

Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL.

CMAJ. 1993 Aug 1;149(3):289-93. Review. No abstract available.

29.

Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy.

Arnold JM, Teasell RW, MacLeod AP, Brown JE, Carruthers SG.

Ann Intern Med. 1993 Apr 15;118(8):619-21. No abstract available.

PMID:
8383935
30.

Quinidine interaction with nifedipine and felodipine: pharmacokinetic and pharmacodynamic evaluation.

Bailey DG, Freeman DJ, Melendez LJ, Kreeft JH, Edgar B, Carruthers SG.

Clin Pharmacol Ther. 1993 Mar;53(3):354-9.

PMID:
8453855
31.

The place of alpha blockers in the antihypertensive armamentarium.

Carruthers SG.

J Clin Pharmacol. 1993 Mar;33(3):260-3. Review.

PMID:
8096522
32.

Cardiovascular risk factors in perspective.

Carruthers SG.

Can Fam Physician. 1993 Feb;39:309-14. Review.

33.

The J-curve--it is clinically relevant?

Carruthers SG.

Can J Cardiol. 1992 Jul-Aug;8(6):563. Review. No abstract available.

PMID:
1504909
34.

The cyclosporin-erythromycin interaction: impaired first pass metabolism in the pig.

Freeman DJ, Grant DR, Carruthers SG.

Br J Pharmacol. 1991 Jul;103(3):1709-12.

35.
36.

Genetic aspects of variability in superficial vein responsiveness to norepinephrine.

Luthra A, Borkowski KR, Carruthers SG.

Clin Pharmacol Ther. 1991 Apr;49(4):355-61.

PMID:
2015725
37.
38.

Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.

Pollak PT, Sharma AD, Carruthers SG.

Am J Cardiol. 1990 May 15;65(18):1185-91.

PMID:
2337027
39.
40.

Synergistic adverse hemodynamic interaction between oral verapamil and propranolol.

Carruthers SG, Freeman DJ, Bailey DG.

Clin Pharmacol Ther. 1989 Oct;46(4):469-77.

PMID:
2791449
41.

Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.

Myers MG, Carruthers SG, Leenen FH, Haynes RB.

CMAJ. 1989 May 15;140(10):1141-6. Review. No abstract available.

42.

A double-blind, randomized trial of PY108-068 in acute ischemic cerebral infarction.

Oczkowski WJ, Hachinski VC, Bogousslavsky J, Barnett HJ, Carruthers SG.

Stroke. 1989 May;20(5):604-8.

PMID:
2655184
43.

Elevation of serum total cholesterol and triglyceride levels during amiodarone therapy.

Pollak PT, Sharma AD, Carruthers SG.

Am J Cardiol. 1988 Sep 15;62(9):562-5.

PMID:
3414548
44.
45.
46.

The centrally acting drugs.

Carruthers SG.

J Cardiovasc Pharmacol. 1988;12 Suppl 8:S74-82. Review.

PMID:
2469905
47.

Cyclosporin-erythromycin interaction in normal subjects.

Freeman DJ, Martell R, Carruthers SG, Heinrichs D, Keown PA, Stiller CR.

Br J Clin Pharmacol. 1987 Jun;23(6):776-8.

48.

Relationships between heart rate and PR interval during physiological and pharmacological interventions.

Carruthers SG, McCall B, Cordell BA, Wu R.

Br J Clin Pharmacol. 1987 Mar;23(3):259-65.

49.

Tolerance and cardiovascular effects of single dose felodipine/beta-blocker combinations in healthy subjects.

Carruthers SG, Bailey DG.

J Cardiovasc Pharmacol. 1987;10 Suppl 1:S169-76.

PMID:
2442512
50.

The influence of age on dorsal hand vein responsiveness to norepinephrine.

Martin SA, Alexieva S, Carruthers SG.

Clin Pharmacol Ther. 1986 Sep;40(3):257-60.

PMID:
3017629

Supplemental Content

Loading ...
Support Center